{"blog": [], "keywords": [{"value": "ALLERGAN INC", "name": "organizations", "rank": "1", "is_major": "N"}, {"value": "Pfizer Inc", "name": "organizations", "rank": "2", "is_major": "Y"}, {"value": "Corporate Taxes", "name": "subject", "rank": "3", "is_major": "Y"}, {"value": "Tax Shelters", "name": "subject", "rank": "4", "is_major": "Y"}, {"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "Obama, Barack", "name": "persons", "rank": "6", "is_major": "N"}, {"value": "Law and Legislation", "name": "subject", "rank": "7", "is_major": "N"}, {"value": "Allergan Inc", "name": "organizations", "rank": "8", "is_major": "Y"}], "web_url": "http://www.nytimes.com/2016/04/06/business/dealbook/tax-inversion-obama-treasury.html", "document_type": "article", "byline": {"person": [{"middlename": "J.", "firstname": "Michael", "role": "reported", "rank": 1, "lastname": "de la MERCED", "organization": ""}, {"lastname": "PICKER", "firstname": "Leslie", "role": "reported", "organization": "", "rank": 2}], "original": "By MICHAEL J. de la MERCED and LESLIE PICKER", "contributor": "Michael D. Shear contributed reporting."}, "type_of_material": "News", "multimedia": [], "section_name": "Business Day", "word_count": "1458", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "The broader reach of regulations, intended to keep companies from cutting deals to move income overseas, appears to have caught many by surprise.", "pub_date": "2016-04-06T04:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Pfizer and Allergan Said to End Merger as Tax Rules Tighten", "main": "Pfizer and Allergan Are Said to End Merger as Tax Rules Tighten"}, "print_page": "1", "snippet": "The broader reach of regulations, intended to keep companies from cutting deals to move income overseas, appears to have caught many by surprise.", "_id": "5703f08338f0d848959becc3", "slideshow_credits": null, "abstract": "Pfizer is planning to ditch plans for $152 billion merger with Allergan, reportedly due to new tax rules introduced by Obama admin as part of efforts to prevent companies from moving income overseas to lessen tax liability."}